BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25805233)

  • 1. Characteristics of Multifocal and Multicentric Breast Cancers.
    Kanumuri P; Hayse B; Killelea BK; Chagpar AB; Horowitz NR; Lannin DR
    Ann Surg Oncol; 2015 Aug; 22(8):2475-82. PubMed ID: 25805233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased lymph node positivity in multifocal and multicentric breast cancer.
    Cabioglu N; Ozmen V; Kaya H; Tuzlali S; Igci A; Muslumanoglu M; Kecer M; Dagoglu T
    J Am Coll Surg; 2009 Jan; 208(1):67-74. PubMed ID: 19228505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of biomarkers in multifocal/multicentric invasive breast carcinomas.
    Pekmezci M; Szpaderska A; Osipo C; Erşahin Ç
    Int J Surg Pathol; 2013 Apr; 21(2):126-32. PubMed ID: 23204031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapy.
    Wong H; Lau S; Cheung P; Wong TT; Parker A; Yau T; Epstein RJ
    BMC Cancer; 2014 Nov; 14():826. PubMed ID: 25385074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: single center experience.
    Ustaalioglu BO; Bilici A; Kefeli U; Şeker M; Oncel M; Gezen C; Gumus M; Demirelli F
    Am J Clin Oncol; 2012 Dec; 35(6):580-6. PubMed ID: 21926901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifocal and multicentric breast cancer: is breast conserving surgery acceptable?
    Ninkovic S; Ninkovic V; Cvetkovic A; Cvetkovic D; Nedovic J; Milosevic B
    J BUON; 2012; 17(1):38-45. PubMed ID: 22517691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative surgery for multifocal/multicentric breast cancer.
    Nijenhuis MV; Rutgers EJ
    Breast; 2015 Nov; 24 Suppl 2():S96-9. PubMed ID: 26303986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?
    Weissenbacher TM; Zschage M; Janni W; Jeschke U; Dimpfl T; Mayr D; Rack B; Schindlbeck C; Friese K; Dian D
    Breast Cancer Res Treat; 2010 Jul; 122(1):27-34. PubMed ID: 20454925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early (<10 mm) HER2-Positive Invasive Breast Carcinomas are Associated with Extensive Diffuse High-Grade DCIS: Implications for Preoperative Mapping, Extent of Surgical Intervention, and Disease-Free Survival.
    Tot T
    Ann Surg Oncol; 2015 Aug; 22(8):2532-9. PubMed ID: 25582746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases".
    Neri A; Marrelli D; Megha T; Bettarini F; Tacchini D; De Franco L; Roviello F
    BMC Surg; 2015 Jan; 15(1):1. PubMed ID: 25586679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality?
    Yerushalmi R; Tyldesley S; Woods R; Kennecke HF; Speers C; Gelmon KA
    Ann Oncol; 2012 Apr; 23(4):876-81. PubMed ID: 21810730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the histopathology and prognosis of bilateral versus unilateral multifocal multicentric breast cancers.
    Kadioğlu H; Özbaş S; Akcan A; Soyder A; Soylu L; Koçak S; Cantürk NZ; Tükenmez M; Müslümanoğlu M
    World J Surg Oncol; 2014 Aug; 12():266. PubMed ID: 25143016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors.
    Tawfik K; Kimler BF; Davis MK; Fan F; Tawfik O
    Hum Pathol; 2012 Jan; 43(1):23-30. PubMed ID: 21777944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Markers and Histologic Subtypes in Patients with Meningeal Carcinomatosis in Breast Cancer.
    Alnajar H; Rosen L; Javidiparsijani S; Al-Ghamdi Y; Gattuso P
    Acta Cytol; 2017; 61(2):140-144. PubMed ID: 28231581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of multifocality and lymph node metastasis on the prognosis and management of microinvasive breast cancer.
    Kapoor NS; Shamonki J; Sim MS; Chung CT; Giuliano AE
    Ann Surg Oncol; 2013 Aug; 20(8):2576-81. PubMed ID: 23468047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of multifocality and tumor burden with various tumor characteristics and survival in early breast cancer.
    Kelemen G; Farkas V; Debrah J; Ormandi K; Voros A; Kaizer L; Varga Z; Lazar G; Kahan Z
    Neoplasma; 2012; 59(5):566-73. PubMed ID: 22668023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and outcomes of patients with multifocal/multicentric and unifocal breast cancer.
    Djordjevic-Jovanovic L; Karanikolic A; Bojic T; Pesic I; Djordjevic M; Marinkovic M
    J BUON; 2017; 22(3):652-657. PubMed ID: 28730770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patients.
    Vandorpe T; Smeets A; Van Calster B; Van Hoorde K; Leunen K; Amant F; Moerman P; Deraedt K; Brouckaert O; Van Huffel S; Wildiers H; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2011 Jul; 128(2):429-35. PubMed ID: 21562708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
    Barth A; Craig PH; Silverstein MJ
    Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients.
    Wolters R; Wöckel A; Janni W; Novopashenny I; Ebner F; Kreienberg R; Wischnewsky M; Schwentner L;
    Breast Cancer Res Treat; 2013 Dec; 142(3):579-90. PubMed ID: 24258258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.